Citi maintains Swiss franc outlook ahead of SNB meeting

Citi analysts anticipate the Swiss National Bank (SNB) will hold steady on interest rates and refrain from currency intervention in the near term, citing potential pharmaceutical tariffs as a key consideration. The firm maintains a long Swiss franc/Japanese yen position, expecting rate differentials to slightly favor the franc if the SNB avoids further negative rate cuts. Despite the SNB likely reiterating intervention and negative rates as policy options, Citi believes the bar for implementing these measures remains high and advises investors to discount related SNB commentary.

Analysis

Citigroup has reiterated its forecast that the Swiss National Bank (SNB) will refrain from implementing negative interest rates or engaging in foreign exchange market interventions in the upcoming months, a stance influenced by potential pharmaceutical tariffs. Consequently, Citi is maintaining a long position on the Swiss franc against the Japanese yen (CHF/JPY) leading into the next SNB meeting. The market currently assigns a low probability to a further reduction in SNB rates into negative territory. Citi anticipates that if the SNB abstains from such measures, interest rate differentials will marginally favor the Swiss franc, potentially leading to a slight appreciation of the currency. While the SNB is expected to continue acknowledging currency intervention and negative rates as available policy instruments, Citi assesses the threshold for their actual deployment as significantly high under current economic conditions, advising investors to largely disregard SNB commentary on these potential actions due to their low likelihood of near-term materialization.

Key Decisions for Investors

• Investors should consider the implications of a stable SNB policy for CHF positions, particularly against currencies like the JPY where rate differentials may shift in the franc's favor.
• Monitor upcoming SNB communications, but assign a low probability to actual intervention or deeper negative rates based on Citi's assessment of the high implementation threshold.
• Keep abreast of developments regarding potential pharmaceutical tariffs, as this is a cited factor in Citi's SNB policy outlook and could influence currency dynamics.